Treatment Information for Healthcare Professionals

Details

• Alternative Title:
  Mpox treatment information for healthcare professionals
• Corporate Authors:
   National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
• Description:
  Updated July 10, 2023 ; Patients are still developing severe mpox. A March 3, 2023, MMWR provides updated clinical treatment considerations about using therapeutics to treat severe mpox cases, including ocular infections, neurologic complications, myopericarditis, complications associated with mucosal lesions, and complications from uncontrolled viral spread.
• Content Notes:
  Interim Clinical Guidance for the Treatment of Mpox -- Current CDC Mpox Studies -- Medical Countermeasures Available for the Treatment of Mpox -- Tecovirimat -- Brincidofovir -- Vaccinia Immune Globulin Intravenous (VIGIV) -- Cidofovir -- References.
• Subjects:
  • Mpox (monkeypox)/drug therapy
  • Mpox (monkeypox)/therapy
• Document Type:
  Text
• Genre:
  Webpage
• Download URL:
  https://stacks.cdc.gov/view/cdc/130780/cdc_130780_DS1.pdf
• File Type:
  [PDF - 305.85 KB]
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:6736a60d12968a957eb7e03e0cce340a130a79ef7fab1ed81754654ab1928ab1b53bfca56756d12342746bf7aa8508243ea16f8e9b8cb85dc419a912a76aeab3